Adenovirus vectors for human gene therapy
- 1 January 2000
- book chapter
- Published by Elsevier
- Vol. 55, 479-505
- https://doi.org/10.1016/s0065-3527(00)55014-3
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administrationGene Therapy, 1999
- Regional Suppression of Tumor Growth byIn VivoTransfer of a cDNA Encoding a Secreted Form of the Extracellular Domain of theflt-1Vascular Endothelial Growth Factor ReceptorHuman Gene Therapy, 1998
- Adenovirus-mediated gene transfer: influence of transgene, mouse strain and type of immune response on persistence of transgene expressionGene Therapy, 1997
- Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vectorGene Therapy, 1997
- Characterization of Factors Involved in Modulating Persistence of Transgene Expression from Recombinant Adenovirus in the Mouse LungHuman Gene Therapy, 1997
- FK506 Immunosuppression to Control the Immune Reactions Triggered by First-Generation Adenovirus-Mediated Gene TransferHuman Gene Therapy, 1995
- Immunosuppression by FK506 Markedly Prolongs Expression of Adenovirus-Delivered Transgene in Skeletal Muscles of Adult Dystrophic [mdx] MiceBiochemical and Biophysical Research Communications, 1995
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachmentCell, 1993
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977